genXone S.A. (WSE: GX1)
Health Care · Biotechnology · PL
zł5.74
-0.69% today · -2.4% 1Y
genXone S.A. (WSE: GX1) operates in the Biotechnology industry within the Health Care sector. The company is valued at $5.17M.
Over the last twelve months the share price has lost 2.4%, trading between 3.81 and 6.96.
Tweenvest scores genXone S.A. across four factors: quality 44/100, value 77/100, growth 0/100. Its strongest factor is value.
GX1 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.17M
- Revenue (TTM)
- $660.20K
- P/E
- —
- EPS
- -0.66
- Dividend yield
- —
- Beta (5Y)
- -0.31
- 52-week high
- zł6.96
- 52-week low
- zł3.81
- Avg volume (3M)
- —
- Shares outstanding
- 3.30M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $441.75 | +0.55% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.61 | +0.34% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €883.80 | -2.02% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $143.00 | -1.43% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.